Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PRAN

Prana Biotechnology Ltd ADS (PRAN)

Prana Biotechnology Ltd ADS
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRAN
DateTimeSourceHeadlineSymbolCompany
01/02/201901:01Business WirePrana Receives First Orphan Drug Designation from the FDA for the Treatment of Multiple System AtrophyNASDAQ:PRANPrana Biotechnology Ltd ADS
02/01/201923:00PR Newswire (US)Life Biosciences LLC leads strategic investment of up to A$44.5 million (US$31.4 million) in PranaNASDAQ:PRANPrana Biotechnology Ltd ADS
05/10/201813:47Business WirePrana Biotechnology: Pre-Clinical Evidence Demonstrates PBT434 as a Potential Treatment for MSANASDAQ:PRANPrana Biotechnology Ltd ADS
04/09/201820:22Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PRANPrana Biotechnology Ltd ADS
09/07/201810:15Business WirePBT434 Data to be Presented at the International Congress of Parkinson’s Disease and Movement DisordersNASDAQ:PRANPrana Biotechnology Ltd ADS
04/07/201811:38Business WireFirst Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian DiseasesNASDAQ:PRANPrana Biotechnology Ltd ADS
14/06/201810:55Business WirePrana to Commence Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian DiseasesNASDAQ:PRANPrana Biotechnology Ltd ADS
18/07/201723:00Business WirePrana Commences Research Collaboration with Takeda for the Treatment of Parkinson's Disease Gastrointestinal NeuropathologyNASDAQ:PRANPrana Biotechnology Ltd ADS
05/07/201723:00Business WirePrana's PBT434 Lowers Alpha-Synuclein and Prevents NeurodegenerationNASDAQ:PRANPrana Biotechnology Ltd ADS
05/06/201722:30Business WirePrana Appoints David Stamler as Chief Medical Officer to Lead Clinical DevelopmentNASDAQ:PRANPrana Biotechnology Ltd ADS
19/10/201602:00Business WireNew Data from Reach2HD Trial Presented at American Neurological Association Annual MeetingNASDAQ:PRANPrana Biotechnology Ltd ADS
28/07/201602:22Business WirePrana Alzheimer's disease data features at world leading conferenceNASDAQ:PRANPrana Biotechnology Ltd ADS
11/04/201622:00Business WirePrana Regains Compliance with NASDAQ Continued Listing Requirements Continues to Work Towards FDA SubmissionNASDAQ:PRANPrana Biotechnology Ltd ADS
27/02/201600:00Business WirePrana Biotechnology Half Year Investor ReportNASDAQ:PRANPrana Biotechnology Ltd ADS
17/11/201501:00Business WirePrana Chief Scientific Advisor Receives Smithsonian American Ingenuity AwardNASDAQ:PRANPrana Biotechnology Ltd ADS
10/11/201500:00Business WirePrana Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price RequirementNASDAQ:PRANPrana Biotechnology Ltd ADS
27/08/201522:00Business WirePrana Reports FY15 Financial ResultsNASDAQ:PRANPrana Biotechnology Ltd ADS
24/07/201523:00PR Newswire (US)Technical Report on Drug Manufacturers - Other Stocks -- Synergy Pharma, Teva Pharma, Orexigen Therapeutics, Prana Biotechnol...NASDAQ:PRANPrana Biotechnology Ltd ADS
01/07/201513:58Business WirePrana Announces Safety Outcomes of Alzheimer’s IMAGINE Extension TrialNASDAQ:PRANPrana Biotechnology Ltd ADS
02/06/201503:21Business WireLa Commission européenne approuve la désignation orpheline pour le PBT2 dans le cadre de la maladie de HuntingtonNASDAQ:PRANPrana Biotechnology Ltd ADS
02/06/201501:20Business WireEuropäische Kommission gewährt PBT2 Orphan-Status für Chorea HuntingtonNASDAQ:PRANPrana Biotechnology Ltd ADS
01/06/201523:00Business WireEuropean Commission Approves PBT2 Orphan Designation for Huntington’s DiseaseNASDAQ:PRANPrana Biotechnology Ltd ADS
28/04/201513:22Business WirePBT2 Recommended for Orphan Designation in EuropeNASDAQ:PRANPrana Biotechnology Ltd ADS
20/11/201403:00Business WireThe Lancet Neurology Publishes Prana's Huntington Disease TrialNASDAQ:PRANPrana Biotechnology Ltd ADS
05/09/201423:49Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNASDAQ:PRANPrana Biotechnology Ltd ADS
05/09/201421:45PR Newswire (US)Prana receives FDA Orphan Drug Designation for PBT2 for Huntington DiseaseNASDAQ:PRANPrana Biotechnology Ltd ADS
18/07/201406:10PR Newswire (US)Prana Alzheimer's disease Development Program updateNASDAQ:PRANPrana Biotechnology Ltd ADS
16/05/201421:39Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PRANPrana Biotechnology Ltd ADS
14/05/201421:42Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PRANPrana Biotechnology Ltd ADS
14/05/201421:30PR Newswire (US)World leader in movement disorders Professor Ira Shoulson joins Prana BoardNASDAQ:PRANPrana Biotechnology Ltd ADS
 Showing the most relevant articles for your search:NASDAQ:PRAN